go back

Ranibizumab (Susvimo) Sustained-Release Implant

Tennessee rates for HCPCS C9093

Injection, ranibizumab, via sustained release intravitreal implant (Susvimo), 0.1 mg

Rates data updated July 2026.

Facilitymedian $138 · 10th–90th $79$4070%20%10th90th$138Professionalmedian $79 · 10th–90th $79$790%50%$79$100.0$200.0

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Need provider-level prices? Contact us.

Insurance Carrier
Aetna
Setting
Facility
Modifier
Global
Typical Low
$79.43
Median
$79.43
Typical High
$138.04
Aetna
Setting
Professional
Modifier
Global
Typical Low
$79.43
Median
$79.43
Typical High
$79.43
Lucent Health
Setting
Facility
Modifier
Global
Typical Low
$407.38
Median
$407.38
Typical High
$407.38